A citation-based method for searching scientific literature

Pasquale Pisapia, Francesco Pepe, Antonino Iaccarino, Roberta Sgariglia, Mariantonia Nacchio, Gianluca Russo, Gianluca Gragnano, Umberto Malapelle, Giancarlo Troncone. Cells 2020
Times Cited: 5







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mutations of the BRAF gene in human cancer.
Helen Davies, Graham R Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg, Jon Teague, Hayley Woffendin, Mathew J Garnett, William Bottomley,[...]. Nature 2002
40


Silencing LGR6 Attenuates Stemness and Chemoresistance via Inhibiting Wnt/β-Catenin Signaling in Ovarian Cancer.
Xiaohong Ruan, Aibin Liu, Meigong Zhong, Jihong Wei, Weijian Zhang, Yingrou Rong, Wanmin Liu, Mingwei Li, Xingrong Qing, Gaowen Chen,[...]. Mol Ther Oncolytics 2019
22
20

ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response.
Andrew N Blackford, Stephen P Jackson. Mol Cell 2017
660
20


Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells.
Maria M Ho, Alvin V Ng, Stephen Lam, Jaclyn Y Hung. Cancer Res 2007
726
20




Paracrine Wnt5a-β-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization.
Fei Zhao, Christine Xiao, Kathy S Evans, Tbalamayooran Theivanthiran, Nicholas DeVito, Alisha Holtzhausen, Juan Liu, Xiaojing Liu, David Boczkowski, Smita Nair,[...]. Immunity 2018
90
20

LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem Cell Population during Temozolomide Therapy in Glioblastoma.
Shivani Baisiwala, Robert R Hall, Miranda R Saathoff, Jack M Shireman, Cheol Park, Shreya Budhiraja, Chirag Goel, Louisa Warnke, Clare Hardiman, Jennifer Y Wang,[...]. Cancers (Basel) 2020
2
50

Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients.
Preetesh Jain, Hagop M Kantarjian, Ahmad Ghorab, Koji Sasaki, Elias J Jabbour, Graciela Nogueras Gonzalez, Rashmi Kanagal-Shamanna, Ghayas C Issa, Guillermo Garcia-Manero, Devendra Kc,[...]. Cancer 2017
58
20

Drug Resistance Driven by Cancer Stem Cells and Their Niche.
Marta Prieto-Vila, Ryou-U Takahashi, Wataru Usuba, Isaku Kohama, Takahiro Ochiya. Int J Mol Sci 2017
213
20

Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.
Bo Cheng, Guosheng Yang, Rui Jiang, Yong Cheng, Haifan Yang, Lijun Pei, Xiaofu Qiu. Oncotarget 2016
26
20


Controversies around epithelial-mesenchymal plasticity in cancer metastasis.
Elizabeth D Williams, Dingcheng Gao, Andrew Redfern, Erik W Thompson. Nat Rev Cancer 2019
133
20

Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry.
Tao Sun, Nan Zhao, Xiu-Lan Zhao, Qiang Gu, Shi-Wu Zhang, Na Che, Xing-Hui Wang, Jing Du, Yi-Xin Liu, Bao-Cun Sun. Hepatology 2010
239
20

Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells.
Marzia Del Re, Elena Arrigoni, Giuliana Restante, Antonio Passaro, Eleonora Rofi, Stefania Crucitta, Filippo De Marinis, Antonello Di Paolo, Romano Danesi. Stem Cells 2018
18
20


A Pan-ALDH1A Inhibitor Induces Necroptosis in Ovarian Cancer Stem-like Cells.
Ilana Chefetz, Edward Grimley, Kun Yang, Linda Hong, Ekaterina V Vinogradova, Radu Suciu, Ilya Kovalenko, David Karnak, Cynthia A Morgan, Mikhail Chtcherbinine,[...]. Cell Rep 2019
49
20


Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression.
Dona Sinha, Priyanka Saha, Anurima Samanta, Anupam Bishayee. Biomolecules 2020
11
20

Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer.
Tiyasha H Ayub, Mignon-Denise Keyver-Paik, Manuel Debald, Babak Rostamzadeh, Thore Thiesler, Lars Schröder, Winfried Barchet, Alina Abramian, Christina Kaiser, Glen Kristiansen,[...]. Oncotarget 2015
37
20

ALDH1 Expression and the Prognosis of Lung Cancer: A Systematic Review and Meta-Analysis.
Dong Wei, Jing-Jing Peng, Hui Gao, Tao Zhang, Yong Tan, Yong-He Hu. Heart Lung Circ 2015
18
20

Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer.
Elizabeth Scheid, Pierre Major, Alain Bergeron, Olivera J Finn, Russell D Salter, Robin Eady, Bader Yassine-Diab, David Favre, Yoav Peretz, Claire Landry,[...]. Cancer Immunol Res 2016
29
20

Tumor angiogenesis: causes, consequences, challenges and opportunities.
Roberta Lugano, Mohanraj Ramachandran, Anna Dimberg. Cell Mol Life Sci 2020
202
20

High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer.
Christel van den Hoogen, Geertje van der Horst, Henry Cheung, Jeroen T Buijs, Jenny M Lippitt, Natalia Guzmán-Ramírez, Freddie C Hamdy, Colby L Eaton, George N Thalmann, Marco G Cecchini,[...]. Cancer Res 2010
262
20

Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis.
J Yan, J De Melo, J-C Cutz, T Aziz, D Tang. Br J Cancer 2014
40
20

Acquired tumor resistance to antiangiogenic therapy: Mechanisms at a glance.
Bahare Zarrin, Farzane Zarifi, Golnaz Vaseghi, Shaghayegh Haghjooy Javanmard. J Res Med Sci 2017
36
20

Prognostic Value of Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma: a Meta-analysis.
Zhaona Fan, Mianxiang Li, Xiaobing Chen, Juan Wang, Xueyi Liang, Hongfei Wang, Zhi Wang, Bin Cheng, Juan Xia. Sci Rep 2017
28
20

Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.
James P Sullivan, Monica Spinola, Michael Dodge, Maria G Raso, Carmen Behrens, Boning Gao, Katja Schuster, Chunli Shao, Jill E Larsen, Laura A Sullivan,[...]. Cancer Res 2010
288
20

Targeting Cancer Stemness in the Clinic: From Hype to Hope.
Caner Saygin, Daniela Matei, Ravindra Majeti, Ofer Reizes, Justin D Lathia. Cell Stem Cell 2019
177
20


The embryonic morphogen, Nodal, is associated with channel-like structures in human malignant melanoma xenografts.
Josephine C McAllister, Qian Zhan, Carsten Weishaupt, Mei-Yu Hsu, George F Murphy. J Cutan Pathol 2010
38
20

Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.
Lucia Ricci-Vitiani, Roberto Pallini, Mauro Biffoni, Matilde Todaro, Gloria Invernici, Tonia Cenci, Giulio Maira, Eugenio Agostino Parati, Giorgio Stassi, Luigi Maria Larocca,[...]. Nature 2010
888
20

Trastuzumab resistance induces EMT to transform HER2(+) PTEN(-) to a triple negative breast cancer that requires unique treatment options.
Joseph P Burnett, Hasan Korkaya, Maria D Ouzounova, Hui Jiang, Sarah J Conley, Bryan W Newman, Lichao Sun, Jamie N Connarn, Ching-Shih Chen, Ning Zhang,[...]. Sci Rep 2015
41
20

Melanoma Immunotherapy: Next-Generation Biomarkers.
Sabrina A Hogan, Mitchell P Levesque, Phil F Cheng. Front Oncol 2018
29
20

Reversing paclitaxel resistance in ovarian cancer cells via inhibition of the ABCB1 expressing side population.
Rachel Eyre, Ian Harvey, Katherine Stemke-Hale, Thomas W J Lennard, Alison Tyson-Capper, Annette P Meeson. Tumour Biol 2014
28
20

Mechanisms of Cancer Resistance to Immunotherapy.
Rilan Bai, Naifei Chen, Lingyu Li, Nawen Du, Ling Bai, Zheng Lv, Huimin Tian, Jiuwei Cui. Front Oncol 2020
30
20

An Overview of Vasculogenic Mimicry in Breast Cancer.
Marco A Andonegui-Elguera, Yair Alfaro-Mora, Rodrigo Cáceres-Gutiérrez, Claudia Haydee Sarai Caro-Sánchez, Luis A Herrera, José Díaz-Chávez. Front Oncol 2020
17
20

The stemness phenotype model.
M H Cruz, A Sidén, G M Calaf, Z M Delwar, J S Yakisich. ISRN Oncol 2012
30
20

A distinct "side population" of cells with high drug efflux capacity in human tumor cells.
C Hirschmann-Jax, A E Foster, G G Wulf, J G Nuchtern, T W Jax, U Gobel, M A Goodell, M K Brenner. Proc Natl Acad Sci U S A 2004
963
20


A new strategy for enhancing antitumor immune response using dendritic cells loaded with chemo-resistant cancer stem-like cells in experimental mice model.
Nahla E El-Ashmawy, Enas A El-Zamarany, Mohamed L Salem, Eman G Khedr, Amera O Ibrahim. Mol Immunol 2019
4
25

p38alpha and p38gamma mediate oncogenic ras-induced senescence through differential mechanisms.
Jinny Kwong, Lixin Hong, Rong Liao, Qingdong Deng, Jiahuai Han, Peiqing Sun. J Biol Chem 2009
55
20

Increased PD-L1 expression in breast and colon cancer stem cells.
Yanheng Wu, Mingshui Chen, Peihong Wu, Chen Chen, Zhi Ping Xu, Wenyi Gu. Clin Exp Pharmacol Physiol 2017
46
20

Homeostatic responses of colonic LGR5+ stem cells following acute in vivo exposure to a genotoxic carcinogen.
Eunjoo Kim, Laurie A Davidson, Roger S Zoh, Martha E Hensel, Bhimanagouda S Patil, Guddadarangavvanahally K Jayaprakasha, Evelyn S Callaway, Clinton D Allred, Nancy D Turner, Brad R Weeks,[...]. Carcinogenesis 2016
10
20

Strategies For Targeting Chronic Myeloid Leukaemia Stem Cells.
Giovanna Carrà, Antonio Cartellà, Beatrice Maffeo, Alessandro Morotti. Blood Lymphat Cancer 2019
5
20

Small-molecule drug repurposing to target DNA damage repair and response pathways.
Jacqueline A Brinkman, Yue Liu, Stephen J Kron. Semin Cancer Biol 2021
6
20

cRGD inhibits vasculogenic mimicry formation by down-regulating uPA expression and reducing EMT in ovarian cancer.
Jiao Tang, Jianguo Wang, Lin Fan, Xiaoxuan Li, Na Liu, Wanxian Luo, Jihui Wang, Yifeng Wang, Ying Wang. Oncotarget 2016
24
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.